Source BioScience, comprised of Source LDPath and Source Genomics, provides industry-leading laboratory services in Genomics and Histopathology, partnering with biotechnology, pharmaceutical, healthcare and academia. Source LDPath provides an end-to-end clinical diagnostic service, from histopathology, including digital pathology and AI, through to molecular diagnostic services. Source LDPath already supports over 85 NHS Trusts and a comprehensive network of Private Healthcare clinics to expand their diagnostic capabilities, ensuring diagnostic results are delivered within clinically actionable timeframes. Source LDPath brings pioneering expertise in digital pathology and AI implementation, helping NHS pathology departments digitise their workflows for streamlined operations and greater diagnostic reporting capacity, tailoring integration touchpoints to the specific requirements of the Hospital or Trust. • Cellular and digital pathology wet laboratory processing • Reporting - access a pool of over 200 specialist consultant pathologists • MDM and Second Opinions • Digital Implementation Support with AI integration • Connectivity and LIMS integration with Source HIVE™ Source Genomics provides a broad portfolio of multi-omic services, delivering high-quality data in Genomics, Spatial Transcriptomics, Proteomics and Epigenomics. Market-leaders in Sanger Sequencing and Next-Generation Sequencing Services, Source Genomics delivers bespoke laboratory expertise to excel your project at rapid turnaround times. • Sanger Sequencing • NGS - WGS, WES, RNA-seq • Oxford Nanopore Sequencing • Olink proteomics • Optical Genome Mapping • 10x Genomics Visium • Bioinformatics • And more Contact us today at enquiries@sourcebioscience.com.
View Top Employees from Source BioScienceWebsite | http://www.sourcebioscience.com/ |
Revenue | $37 million |
Employees | 224 (224 on RocketReach) |
Founded | 2003 |
Phone | +44 115 973 9012 |
Fax | +44 115 973 9021 |
Technologies |
JavaScript,
HTML,
Google Analytics
+40 more
(view full list)
|
Industry | Biotechnology Research, Medical Testing & Clinical Laboratories, Biotechnology, DNA Sequencing, Healthcare, Science and Engineering, Genotyping, Health Care, Gene Expression, Antibodies, Clones, Histopathology, Diagnostic testing, Cytology, Genomic services, Next Generation Sequencing, Bioinformatics, HPV testing, Stability Storage, Clinical trials, Drug development, Analytical Testing |
Web Rank | 976866 |
Keywords | Source Bioscience, Sure Path Lbc, Microsatellite Genotyping, Pharmaceutical Stability Cabinet, Rp23-374l11 Bac Clone |
Competitors | Ambry Genetics, Azenta Japan corp., DNA Link, IMGM Laboratories GmbH, PreventionGenetics |
SIC | SIC Code 807 Companies, SIC Code 80 Companies |
NAICS | NAICS Code 42469 Companies, NAICS Code 424690 Companies, NAICS Code 621 Companies, NAICS Code 6215 Companies, NAICS Code 62 Companies, NAICS Code 62151 Companies, NAICS Code 42 Companies, NAICS Code 4246 Companies, NAICS Code 424 Companies |
Looking for a particular Source BioScience employee's phone or email?
The Source BioScience annual revenue was $37 million in 2024.
Tom Burr is the Chief Scientific Officer of Source BioScience.
224 people are employed at Source BioScience.
The NAICS codes for Source BioScience are [42469, 424690, 621, 6215, 62, 62151, 42, 4246, 424].
The SIC codes for Source BioScience are [807, 80].